Literature DB >> 16931847

Managing conjunctivitis in general practice: research into management strategies for acute infective conjunctivitis.

Scott J Robbie, Kashif Qureshi, Shahram Kashani, Muhammad A Qureshi.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16931847      PMCID: PMC1553501          DOI: 10.1136/bmj.333.7565.446-c

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Evaluation of polymerase chain reaction for the detection of adenoviruses in conjunctival swab specimens using degenerate primers in comparison with direct immunofluorescence.

Authors:  Ursula Weitgasser; Eva Maria Haller; Yosuf El-Shabrawi
Journal:  Ophthalmologica       Date:  2002 Sep-Oct       Impact factor: 3.250

2.  Bacterial Infection in the Conjunctiva of Patients with Adenoviral Conjunctivitis.

Authors:  Y Watanabe; E Uchio; N Itoh; N Usui; H Nakagawa; K Inoue; R Hinokuma; Y Asato; K Aoki; S Ohno
Journal:  Jpn J Ophthalmol       Date:  2001-01       Impact factor: 2.447

3.  Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms.

Authors:  Remco P Rietveld; Gerben ter Riet; Patrick J E Bindels; Jacobus H Sloos; Henk C P M van Weert
Journal:  BMJ       Date:  2004-06-16

4.  A comparison of methods for detecting adenovirus type 8 keratoconjunctivitis during a nosocomial outbreak in a Neonatal Intensive Care Unit.

Authors:  Elena Percivalle; Antonella Sarasini; Maria Torsellini; Loredana Bruschi; Elena Antoniazzi; M Grazia Revello; Giuseppe Gerna
Journal:  J Clin Virol       Date:  2003-12       Impact factor: 3.168

5.  A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice.

Authors:  Hazel A Everitt; Paul S Little; Peter W F Smith
Journal:  BMJ       Date:  2006-07-17
  5 in total
  1 in total

1.  Systematic risks from chloramphenicol eye drops.

Authors:  C I Phillips
Journal:  Br J Gen Pract       Date:  2010-02       Impact factor: 5.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.